De Novo persistent post-lung transplantation HLA donor-specific antibodies (DSA) but not performed DSA are associated with worse survival and a higher risk of developing chronic lung allograft dysfunction

Christophe Picard (1, 2) , Agnes Basire (1, 2) , Anderson Loundou (3) , Matthieu Pelardy (4) , Chiaroni Jacques (2, 1) , Pascal Thomas (5) , Carine Gomez (5) , M Reynaud-Gaubert (6)

1 EFS - Alpes-Méditerranée - Etablissement Français du Sang - Alpes-Méditerranée
2 ADES - Anthropologie bio-culturelle, Droit, Ethique et Santé
3 Unité d'Aide Méthodologique
4 LA CONCEPTION - Hôpital de la Conception [CHU - APHM]
5 Hôpital Nord [CHU - APHM]
6 AMU - Aix Marseille Université

Domaines: Sciences du Vivant [q-bio]

Christophe Picard, Agnes Basire, Anderson Loundou, Matthieu Pelardy, Chiaroni Jacques, et al.. De Novo persistent post-lung transplantation HLA donor-specific antibodies (DSA) but not performed DSA are associated with worse survival and a higher risk of developing chronic lung allograft dysfunction. Archives of transplantation, 2018, 2 (1). ⟨hal-02137804⟩